Aridis Pharmaceuticals

+$0.07 (+1.12%) As of 3:09 PM UTC today

Why Robinhood?

You can buy or sell ARDS and other stocks, options, and ETFs commission-free!

About ARDS

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201.

CEO
Vu L. Truong
Employees
33
Headquarters
Los Gatos, California
Founded
2003

ARDS Key Statistics

Market Cap
69.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.69K
High Today
$6.32
Low Today
$6.20
Open Price
$6.20
Volume
663.00
52 Week High
$9.97
52 Week Low
$4.70

ARDS Earnings

-$0.87
-$0.58
-$0.29
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.62 per share
Actual
-$0.77 per share

You May Also Like

WHLRP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure